Demetra
FranceWho owns Demetra?
Demetra is a French MedTech company, currently owned by DeA Capital Alternative Funds SGR since 2023 and Astorg. It changed hands in 2023, when Alcedo SGR sold.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
- ·Co-held by Astorg and DeA Capital Alternative Funds SGR since 2021.
- ·Average hold across 2 realized cycles: 6 years.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Keensight Capital sold Demetra Holding to Astorg in 2021 after 5 years.
Alcedo SGR sold Demetra to Alcedo V / Taste of Italy 2 in 2023 after 6 years.
More from Taste of Italy 2
Other portfolio companies in the same fund.
Italy
Spain
More PE-backed in MedTech
Comparable medtech deals from other GPs.
US
GermanyQuestions
Who owns Demetra?
Demetra is currently owned by DeA Capital Alternative Funds SGR and Astorg, through Taste of Italy 2, since 2023.
When did DeA Capital Alternative Funds SGR and 1 other acquire Demetra?
DeA Capital Alternative Funds SGR and 1 other acquired Demetra in 2023.
Who did Demetra sell to?
Alcedo SGR sold Demetra to Alcedo V / Taste of Italy 2 in 2023 (Continuation Vehicle). Keensight Capital sold Demetra to Astorg in 2021 (Secondary).
Who has owned Demetra over time?
Demetra has been through 4 private-equity ownership periods: Keensight Capital · via Keensight Nova V · 2016–2021 · sold to Astorg · (Secondary); Alcedo SGR · via Alcedo IV · 2017–2023 · sold to Alcedo V / Taste of Italy 2 · (Continuation Vehicle); Astorg · via Astorg VII · since 2021; DeA Capital Alternative Funds SGR · via Taste of Italy 2 · since 2023.